Category Archives: Press Releases

Abstracts for rHEALTH’s Factor VIII and Platelet Tests Accepted for Poster and Oral Presentations at Upcoming AACC 2019 Meeting

rHEALTH tests to be presented at the industry’s leading annual conference for laboratory medicine   CAMBRIDGE, Mass., July 11, 2019 – rHEALTH LLC, and its affiliate DNA Medicine Institute, Inc., today announced that both of its abstracts have been accepted via peer-review from for the 2019 American Association of Clinical Chemistry (AACC) meeting.  The titles and details...
Read more

rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection

rHEALTH Nanostrips, Vitals Device, and Fluidics Module to Receive U.S. Patent Protection.  Expands patent protection for diagnose yourself, anywhere technology CAMBRIDGE, Mass., May 21, 2019 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, today announced that three separate aspects of its technology platform has received a Notice of Allowance and two Issue Notifications from the...
Read more

rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes

rHEALTH Technology Receives Notice of Allowance from US Patent Office for Multiplexed Tests in Small Sample Volumes This patent enables rHEALTH’s unique technology to measure many analytes in a given small volume sample at home or in the clinic CAMBRIDGE, Mass., January 23, 2019 /PRWeb/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that...
Read more

rHEALTH Technology Receives Notice of Allowance for New U.S. Patent Covering Small Volume Sample Consumable and Loader

CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-iReach/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/645,388, entitled “Sample Consumable and Loader” filed by its affiliate company, DNA Medicine Institute (DMI). This...
Read more

rHEALTH Technology Awarded in NASA’s Civilian Commercialization Readiness Pilot Program (CCRPP)

CAMBRIDGE, Mass., Aug. 20, 2018 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is a subject of NASA’s Civilian Commercial Readiness Pilot Program (CCRPP). Recipients of CCRPP awards must not only demonstrate maturation of technology that aligns with NASA interests, but also...
Read more